229 related articles for article (PubMed ID: 36094344)
1. Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment.
Huang Y; Lin X; Yu S; Chen R; Chen W
ACS Synth Biol; 2022 Oct; 11(10):3134-3153. PubMed ID: 36094344
[TBL] [Abstract][Full Text] [Related]
2. Engineering probiotics as living diagnostics and therapeutics for improving human health.
Zhou Z; Chen X; Sheng H; Shen X; Sun X; Yan Y; Wang J; Yuan Q
Microb Cell Fact; 2020 Mar; 19(1):56. PubMed ID: 32131831
[TBL] [Abstract][Full Text] [Related]
3. Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics.
Lynch JP; Goers L; Lesser CF
Trends Pharmacol Sci; 2022 Sep; 43(9):772-786. PubMed ID: 35232591
[TBL] [Abstract][Full Text] [Related]
4. Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox.
Pedrolli DB; Ribeiro NV; Squizato PN; de Jesus VN; Cozetto DA;
Trends Biotechnol; 2019 Jan; 37(1):100-115. PubMed ID: 30318171
[TBL] [Abstract][Full Text] [Related]
5. Advanced probiotics: bioengineering and their therapeutic application.
Parvin T; Sadras SR
Mol Biol Rep; 2024 Feb; 51(1):361. PubMed ID: 38403783
[TBL] [Abstract][Full Text] [Related]
6. Engineered probiotics.
Ma J; Lyu Y; Liu X; Jia X; Cui F; Wu X; Deng S; Yue C
Microb Cell Fact; 2022 Apr; 21(1):72. PubMed ID: 35477497
[TBL] [Abstract][Full Text] [Related]
7. Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases.
Meng J; Liu S; Wu X
Crit Rev Microbiol; 2024 May; 50(3):300-314. PubMed ID: 36946080
[TBL] [Abstract][Full Text] [Related]
8. Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives.
Guo J; Zhou B; Niu Y; Liu L; Yang L
J Diabetes Metab Disord; 2023 Dec; 22(2):1029-1038. PubMed ID: 37975092
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.
Ozdemir T; Fedorec AJH; Danino T; Barnes CP
Cell Syst; 2018 Jul; 7(1):5-16. PubMed ID: 30048620
[TBL] [Abstract][Full Text] [Related]
10. Engineering probiotics for therapeutic applications: recent examples and translational outlook.
Aggarwal N; Breedon AME; Davis CM; Hwang IY; Chang MW
Curr Opin Biotechnol; 2020 Oct; 65():171-179. PubMed ID: 32304955
[TBL] [Abstract][Full Text] [Related]
11. Engineering Diagnostic and Therapeutic Gut Bacteria.
Landry BP; Tabor JJ
Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
[TBL] [Abstract][Full Text] [Related]
12. Efficient engineered probiotics using synthetic biology approaches: A review.
Yadav M; Shukla P
Biotechnol Appl Biochem; 2020 Jan; 67(1):22-29. PubMed ID: 31538358
[TBL] [Abstract][Full Text] [Related]
13. Probiotics: Isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics.
Karimi O; Pena AS
Drugs Today (Barc); 2003 Aug; 39(8):565-97. PubMed ID: 14566382
[TBL] [Abstract][Full Text] [Related]
14. Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice.
Zou ZP; Du Y; Fang TT; Zhou Y; Ye BC
Cell Host Microbe; 2023 Feb; 31(2):199-212.e5. PubMed ID: 36758520
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Biology and the Gut Microbiome.
Dou J; Bennett MR
Biotechnol J; 2018 May; 13(5):e1700159. PubMed ID: 28976641
[TBL] [Abstract][Full Text] [Related]
16. Probiotics in inflammatory bowel disease: a critical review.
Tamboli CP; Caucheteux C; Cortot A; Colombel JF; Desreumaux P
Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):805-20. PubMed ID: 14507590
[TBL] [Abstract][Full Text] [Related]
17. Synthetic biology in probiotic lactic acid bacteria: At the frontier of living therapeutics.
Mays ZJ; Nair NU
Curr Opin Biotechnol; 2018 Oct; 53():224-231. PubMed ID: 29550614
[TBL] [Abstract][Full Text] [Related]
18. Advancements in synthetic biology-based bacterial cancer therapy: A modular design approach.
Arboleda-García A; Alarcon-Ruiz I; Boada-Acosta L; Boada Y; Vignoni A; Jantus-Lewintre E
Crit Rev Oncol Hematol; 2023 Oct; 190():104088. PubMed ID: 37541537
[TBL] [Abstract][Full Text] [Related]
19. Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases.
Barra M; Danino T; Garrido D
Front Bioeng Biotechnol; 2020; 8():265. PubMed ID: 32296696
[TBL] [Abstract][Full Text] [Related]
20. Probiotics in pediatric inflammatory bowel diseases.
Gulati AS; Dubinsky MC
Curr Gastroenterol Rep; 2009 Jun; 11(3):238-47. PubMed ID: 19463225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
